Data from our lab and others has demonstrated that hypoxia-induced HO-1 upregulation contributes to the resistance of cancer cells to conventional therapies, such as radiotherapy and chemotherapy, which often rely on oxygen-dependent mechanisms to induce cell death [80,93,94]. This evidence concerns the gene HMOX1 and cancer.